Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
about
Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study.Development and Validation of a RP-HPLC Method for Estimation of Prulifloxacin in Tablet Dosage Form.Advances in the treatment of travelers' diarrhea.Antimicrobial activity of prulifloxacin in comparison with other fluoroquinolones against community-acquired urinary and respiratory pathogens isolated in Greece.14-day prulifloxacin treatment of acute uncomplicated cystitis in women with recurrent urinary tract infections: a prospective, open-label, pilot trial with 6-month follow-up.
P2860
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@ast
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@en
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@nl
type
label
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@ast
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@en
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@nl
prefLabel
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@ast
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@en
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@nl
P2860
P356
P1433
P1476
Prulifloxacin: clinical studies of a broad-spectrum quinolone agent.
@en
P2093
Cesare Selli
Gianluca Giannarini
P2860
P356
10.2217/17460913.4.1.13
P577
2009-02-01T00:00:00Z